Treatment or improvement of metabolic disorders by the use of GLP-1 receptor agonists, combined with the polymerized protein of gstrico inhibitor receptor
Methods for the treatment of metabolic diseases and disorders are provided, using ingredients including a specific antigen binding protein, an analgesic for aggregation into the GLP-1 receptor. In all cases, metabolic diseases are type 2 diabetes, obesity, degreasing, high glucose, high insulin or diabetic nephropathy.Se proveen métodos para tratar enfermedades y trastornos metabólicos usando una composición que comprende una proteína de unión al antígeno específica para el polipéptido GIPR conjugada a un agonista del receptor GLP-1. En varias modalidades la enfermedad o trastorno metabólico es la diabetes tipo 2, obesidad, dislipidemia, niveles elevados de glucosa, niveles elevados de insulina o nefropatía diabética.
